Mapping of genetic factors influencing the weight of cystic fibrosis knockout mice

Mammalian Genome

Volumn 13, Issue 11, 2002, Pages 614-618

  Haston, Christina K ^a,c,e   Corey, Mary ^b,d   Tsui, Lap Chee ^a,c,f  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 13; CHROMOSOME 6; CHROMOSOME 7; CONTROLLED STUDY; CYSTIC FIBROSIS; GENE MAPPING; GENETIC DISORDER; GENOTYPE; HERITABILITY; KNOCKOUT MOUSE; LUNG DISEASE; MOUSE; NONHUMAN; PHENOTYPE; QUANTITATIVE TRAIT LOCUS; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHROMOSOME MAP; DISEASE MODEL; GENETIC LINKAGE; GENETICS; MOUSE MUTANT; STATISTICAL MODEL;

ANIMALS; BODY WEIGHT; CHROMOSOME MAPPING; CYSTIC FIBROSIS; DISEASE MODELS, ANIMAL; LINEAR MODELS; LINKAGE (GENETICS); MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 0036855271     PISSN: 09388990     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00335-002-2195-2     Document Type: Article

References (37)

1. Bhura-Bandali FN, Suh M, Man SF, Clandinin MT (2000) The DeltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells. J Nutr 130, 2870-2875
2. Cardim HJ, Lopes CM, Giannella-Neto D, da Fonseca AM, Pinotti JA (2001) The insulin-like growth factor-1 system and hormone replacement therapy. Fertil Steril 75, 282-287
3. Chagnon YC, Perusse L, Weisnagel SJ, Rankinen T, Bouchard C (2000) The human obesity gene map: The 1999 update. Obes Res 8, 89-117
4. Churchill GA, Doerge RW (1994) Empirical threshold values for quantitative trait mapping. Genetics 138, 963-971
5. Davidson DJ, Rolfe M (2001) Mouse models of cystic fibrosis. Trends Genet 17, S29-S37
6. Davis PB, Drumm M, Konstan MW (1996) Cystic fibrosis. Am J Respir Crit Care Med 154, 1229-1256
7. Dietrich WF, Miller J, Steen R, Merchant MA, Damron-Boles D et al. (1996) A comprehensive genetic map of the mouse genome. Nature 380, 149-152
8. Ewart-Toland A, Mounzih K, Qiu J, Chehab FF (1999) Effect of the genetic background on the reproduction of leptin-deficient obese mice. Endocrinology 140, 732-738
9. Freedman SD, Katz MH, Parker EM, Laposata M, Urman MY et al. (1999) A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in Cftr(-/-) mice. Proc Natl Acad Sci USA 96, 13995-14000
10. Ip WF, Bronsveld I, Kent G, Corey M, Durie PR (1996) Exocrine pancreatic alterations in long-lived surviving cystic fibrosis mice. Pediatr Res 40, 242-249
11. Haston CK, McKerlie C, Newbigging S, Corey M, Rozmahel R et al. (2002) Detection of modifier loci influencing the lung phenotype of cystic fibrosis knockout mice. Mamm Genome, in press
12. Kent G, Oliver M, Foskett JK, Frndova H, Durie P et al. (1996) Phenotypic abnormalities in long-term surviving cystic fibrosis mice. Pediatr Res 40, 233-241
13. Kent G, Iles R, Bear CE, Huan L-J, Griesenbach U et al. (1997) Lung disease in mice with cystic fibrosis. J Clin Invest 100, 3060-3069
14. Kleyn PW, Fan W, Kovats SG, Lee JJ, Pulido JC et al. (1996) Identification and characterization of the mouse obesity gene tubby: A member of a novel gene family. Cell 85, 281-290
15. Kluge R, Giesen K, Bahrenberg G, Plum L, Ortlepp JR et al. (2000) Quantitative trait loci for obesity and insulin resistance (Nob1, Nob2) and their interaction with the leptin receptor allele (LeprA720T/T1044I) in New Zealand obese mice. Diabetologia. 43, 1565-1572
16. Lai HC, Corey M, FitzSimmons S, Kosorok MR, Farrell PM (1999) Comparison of growth status of patients with cystic fibrosis between the United States and Canada. Am J Clin Nutr 69, 531-538
17. Lander ES, Botstein D (1989) Mapping Mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 121, 185-199
18. Lander E, Kruglyak L (1995) Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet 11, 241-247
19. Lloyd-Still JD, Bibus DM, Powers CA, Johnson SB, Holman RT (1996) Essential fatty acid deficiency and predisposition to lung disease in cystic fibrosis. Acta Paediatr 85, 1426-1432
20. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A (2001) Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229, 141-162
21. Lynch M, Walsh B (1998) Genetics and Analysis of Quantitative Traits. (Sunderland, Mass.: Sinauer, Associates Inc.)
22. Manly KF, Olson JM (1999) Overview of QTL mapping software and introduction to MapManager QT. Mamm Genome 10, 327-334. http://mcbio.med.buffalo.edu/mapmgr.html.
23. Mouse Genome Database (MGD), Mouse Genome Informatics, The Jackson Laboratory, Bar Harbor, Maine. (URL:http://www.informatics.jax.org/) April 2002.
24. Murphy LJ, Barron DJ (1993) The IGFs and their binding proteins in murine development. Mol Reprod Dev 35, 376-381
25. Pardo-Manuel de Villena F, de la Casa-Esperon E, Briscoe TL, Malette JM, Sapienza C (2000) Male-offspring-specific, haplotype-dependent, nonrandom cosegregation of alleles at loci on two mouse chromosomes. Genetics 154, 351-356
26. Pencharz PB, Durie PR (2000) Pathogenesis of malnutrition in cystic fibrosis, and its treatment. Clin Nutr 19, 387-394
27. Reifsnyder PC, Churchill G, Leiter EH (2000) Maternal environment and genotype interact to establish diabesity in mice. Genome Res 10, 1568-1578
28. Rozmahel R, Wilschanski M, Matin A, Plyte S, Oliver M et al. (1996) Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet 12, 280-287
29. Sharma R, Florea VG, Bolger AP, Doehner W, Florea ND et al. (2001) Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax 56, 746-750
30. Snouwaert J, Brigman KK, Latour AM, Malouf NN, Boucher RC et al. (1992) An animal model for cystic fibrosis made by gene targetting. Science 257, 1083-1088
31. Steinkamp G, Demmelmair H, Ruhl-Bagheri I, von der Hardt H, Koletzko B (2000) Energy supplements rich in linoleic acid improve body weight and essential fatty acid status of cystic fibrosis patients. J Pediatr Gastroenterol Nutr 31, 418-423
32. Strandvik B (1989) Relation between essential fatty acid metabolism and gastrointestinal symptoms in cystic fibrosis. Acta Paediatr Scand Suppl 363, 58-63
33. Stubdal H, Lynch CA, Moriarty A, Fang Q, Chickering T et al. (2000) Targeted deletion of the tub mouse obesity gene reveals that tubby is a loss-of-function mutation. Mol Cell Biol 20, 878-882
34. Taylor AM, Thomson A, Bruce-Morgan C, Ahmed ML, Watts A et al. (1999) The relationship between insulin, IGF-1 and weight gain in cystic fibrosis. Clin Endocrinol 51, 659-665
35. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM (1998) PPARY promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241-252
36. Yu H, Nasr SZ, Deretic V (2000) Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis. Infect Immun 68, 2142-2147
37. Zemel BS, Jawad AF, FitzSimmons S, Stallings VA (2000) Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: Analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J Pediatr 137, 374-380